Analysis of the RELN gene as a genetic risk factor for autism.

Department of Medicine, Center for Human Genetics, IGSP, Duke University Medical Center, Durham, NC, USA.
Molecular Psychiatry (Impact Factor: 15.15). 07/2005; 10(6):563-71. DOI: 10.1038/
Source: PubMed

ABSTRACT Several genome-wide screens have indicated the presence of an autism susceptibility locus within the distal long arm of chromosome 7 (7q). Mapping at 7q22 within this region is the candidate gene reelin (RELN). RELN encodes a signaling protein that plays a pivotal role in the migration of several neuronal cell types and in the development of neural connections. Given these neurodevelopmental functions, recent reports that RELN influences genetic risk for autism are of significant interest. The total data set consists of 218 Caucasian families collected by our group, 85 Caucasian families collected by AGRE, and 68 Caucasian families collected at Tufts University were tested for genetic association of RELN variants to autism. Markers included five single-nucleotide polymorphisms (SNPs) and a repeat in the 5'-untranslated region (5'-UTR). Tests for association in Duke and AGRE families were also performed on four additional SNPs in the genes PSMC2 and ORC5L, which flank RELN. Family-based association analyses (PDT, Geno-PDT, and FBAT) were used to test for association of single-locus markers and multilocus haplotypes with autism. The most significant association identified from this combined data set was for the 5'-UTR repeat (PDT P-value=0.002). These analyses show the potential of RELN as an important contributor to genetic risk in autism.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Abstract Genetic risk factors acting during pregnancy or early after birth have been proposed to account for the exponential increase of autism diagnoses in the past 20 years. In particular, a potential link with exposure to environmental mercury has been suggested. Male sex constitutes a second risk factor for autism. A third potential genetic risk factor is decreased Reelin expression. Male heterozygous reeler (rl+/-) mice show an autism-like phenotype, including Purkinje cells (PCs) loss and behavioural rigidity. We evaluated the complex interactions between 3 risk factors, i.e. genetic status, sex, and exposure to methylmercury (MeHg), in rl+/- mice. Mice were exposed to MeHg during the prenatal and early postnatal period, either at a subtoxic dose (2ppm in Dams' drinking water), or at a toxic dose (6ppm Dams' drinking water), based on observations in other rodent species and mice strains. We show that: a) 2ppm MeHg does not cause PCs loss in the different animal groups, and does not enhance PCs loss in rl+/- males; consistent with a lack of overt neurotoxicity, 2ppm MeHg per se does not cause behavioural alterations (separation-induced ultrasonic calls in newborns, or sociability and social preference in adults); b) in stark contrast, 6ppm MeHg causes a dramatic reduction of PCs number in all groups, irrespective of genotype and sex. Cytochrome C release from mitochondria of PCs is enhanced in 6ppm MeHg-exposed groups, with a concomitant increase of μ-calpain active subunit. At the behavioural level, 6ppm MeHg exposure strongly increases ultrasonic vocalizations in all animal groups. Notably, 6ppm MeHg significantly decreases sociability in rl+/- male mice, while the 2ppm group does not show such as decrease. At a subtoxic dose, MeHg does not enhance the autism-like phenotype of male rl+/- mice. At the higher MeHg dose, the scenario is more complex, with some "autism-like" features (loss of sociability, preference for sameness) being evidently affected only in rl+/- males, while other neuropathological and behavioural parameters being altered in all groups, independently from genotype and sex. Mitochondrial abnormalities appear to play a crucial role in the observed effects.
    NeuroToxicology 10/2014; DOI:10.1016/j.neuro.2014.09.006 · 3.05 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Currently, there are about 20 antiepileptic drugs on market. Still, seizures in about 30% of patients with epilepsy are not adequately controlled, or the drugs cause quality-of-life-compromising adverse events. Importantly, there are no treatments to combat epileptogenesis, a process that leads to the development of epilepsy and its progression. To fill the gaps in the treatment of epilepsy, there is an urgent need for identification of novel treatment targets. Data emerging over the recent years have shown that different components of the extracellular matrix (ECM) contribute to many components of tissue reorganization during epileptogenesis and the ECM is also a major regulator of synaptic excitability. Here, we review the role of urokinase-type plasminogen activator receptor interactome, matrix metalloproteinases, tenascin-R, and LGI1 in epileptogenesis and ictogenesis. Moreover, the role of the ECM in epilepsy-related comorbidities is reviewed. As there is active development of new imaging methods, we also summarize the data available on imaging of the ECM in epilepsy.
    Progress in brain research 01/2014; 214:229-62. DOI:10.1016/B978-0-444-63486-3.00011-6 · 4.19 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Reelin has recently attracted attention because of its connection to several neuropsychiatric diseases. We previously reported the finding that prior transplantation of GABAergic neuron precursor cells into the medial prefrontal cortex (mPFC) of mice significantly prevented the induction of cognitive and sensory-motor gating deficits induced by phencyclidine (PCP). The majority of the precursor cells transplanted into the mPFC of the recipient mice differentiated into members of a somatostatin/Reelin-expressing class of GABAergic interneurons. These findings raised the possibility that Reelin secreted by the transplanted cells plays an important role in preventing the deficits induced by PCP. In this study, we investigated whether Reelin itself has a preventive effect on PCP-induced behavioral phenotypes by injecting conditioned medium containing Reelin into the lateral ventricle of the brains of 6- to 7-week-old male mice before administrating PCP. Behavioral analyses showed that the prior Reelin injection had a preventive effect against induction of the cognitive and sensory-motor gating deficits associated with PCP. Moreover, one of the types of Reelin receptor was found to be expressed by neurons in the mPFC. The results of this study point to the Reelin signaling pathway as a candidate target for the pharmacologic treatment of neuropsychiatric diseases.
    Neuroscience Research 01/2015; DOI:10.1016/j.neures.2014.12.013 · 2.15 Impact Factor

Full-text (2 Sources)

Available from
May 21, 2014